Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Response Study of Dry Powder Mannitol in Cystic Fibrosis
NCT00251056Phase 2Completed
- Sponsor
- Syntara Limited
- Start
- Oct 2005
- Primary completion
- Aug 2008
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, open-label trial of Bronchitol in cystic fibrosis (CF) (4 arms), sponsored by Syntara Limited. Primary endpoint: Forced Expiratory Volume in 1 Second at 2 weeks. Started Oct 2005; status: completed.
02
Drugs
Bronchitol
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00251056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251056.